Drawing for SCIQ

USPTO serial 99864474

SCIQ

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
ANKRAH, NAAKWAMA S
Law office
TMEG LAW OFFICE 109

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with SCIQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christine Lebron-Dykeman

Christine Lebron-Dykeman MCKEE, VOORHEES & SEASE, PLC801 Grand Ave., Ste. 3200Des Moines, IA 50309-2721United States

Goods and services

ClassDescriptionStatusFirst use
009Platform software; health monitoring software; health monitoring mobile application software; educational software relating to healthcare; educational mobile application software relating to healthcare; computer software for use in medical decision support systems; machine learning software for healthcare; artificial intelligence software for healthcare; virtual reality software for medical teaching; software for analysis of medical and healthcare dataACTIVE—
035Data collection services; maintaining personal medical history records and files; compilation of statistical data relating to medical research; provision of business statistical information relating to medical mattersACTIVE—
038Providing user access to platforms on the Internet; providing user access to databases via a platform on the Internet; electronic data exchange services; telecommunications information; data transmission; data transfer services; communications services for the exchange of data in electronic form; electronic exchange of data stored in databases accessible via telecommunication networks; electronic data exchange, storage and transfer services for the healthcare, pharmaceutical and medical industryACTIVE—
042Design and development of computer hardware and software; software as a service [SaaS]; software as a service [SaaS] for the healthcare, pharmaceutical and medical industry; computer software design; application software design and development; software design and development for the healthcare, pharmaceutical and medical industry; Development of application software for delivery of multimedia content; hosting technology platforms on the Internet; platform as a service [PaaS]; platform as a service [PaaS] for the healthcare, pharmaceutical and medical industry; platform as a services [PaaS] featuring software platforms for the healthcare, pharmaceutical and medical industry; technical support services relating to computer software and applications; providing temporary use of non-downloadable software applications accessible via a web site; medical research services; scientific research in the field of pharmacy; pharmacological research services; electronic storage of data; electronic storage of data for the healthcare, pharmaceutical and medical industry; electronic data storage services; design and development of data storage systems; information and advice in relation to the aforesaidACTIVE—
044Healthcare services; pharmaceutical services; medical services; dentistry services; health assessment services; health care services in domestic homes; healthcare consultancy; medical analysis for the diagnosis and treatment of persons including x-ray examinations and taking blood samples; pharmacy advice; provision of nursing care; pharmaceutical advisory services; collection of information relating to the use of pharmaceutical products; clinical services; design of homecare plans and packages; pharmacist services to make up prescriptions; medical analysis services relating to the treatment of patients; providing healthcare information by telephone; home healthcare services; home nursing aid services; provision of health care services in domestic homes; outpatient and inpatient care services; provision of medical treatment; medical and healthcare information servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Oct 14, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 14, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 14, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 8, 2026DOCKASSIGNED TO EXAMINER—
Oct 7, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 4, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 4, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance